Erratum: Long-term survival of occult hepatitis B associated hepatocellular carcinoma following surgery and antiviral therapy
The ethical approval and consent to participation information were missing in the DECLARATIONS section due to the production issue. The original article has been updated.
Cite This Article
Export citation file: BibTeX | RIS
OAE Style
Boortalary T, Rosato E, Roth C, Ren XD, Lin SY, Hann HW. Erratum: Long-term survival of occult hepatitis B associated hepatocellular carcinoma following surgery and antiviral therapy. Hepatoma Res 2022;8:33. http://dx.doi.org/10.20517/2394-5079.2022.64
AMA Style
Boortalary T, Rosato E, Roth C, Ren XD, Lin SY, Hann HW. Erratum: Long-term survival of occult hepatitis B associated hepatocellular carcinoma following surgery and antiviral therapy. Hepatoma Research. 2022; 8: 33. http://dx.doi.org/10.20517/2394-5079.2022.64
Chicago/Turabian Style
Boortalary, Tina, Ernest Rosato, Christopher Roth, Xiangdong David Ren, Selena Y. Lin, Hie-Won Hann. 2022. "Erratum: Long-term survival of occult hepatitis B associated hepatocellular carcinoma following surgery and antiviral therapy" Hepatoma Research. 8: 33. http://dx.doi.org/10.20517/2394-5079.2022.64
ACS Style
Boortalary, T.; Rosato E.; Roth C.; Ren XD.; Lin SY.; Hann H.W. Erratum: Long-term survival of occult hepatitis B associated hepatocellular carcinoma following surgery and antiviral therapy. Hepatoma. Res. 2022, 8, 33. http://dx.doi.org/10.20517/2394-5079.2022.64
Comments
Comments must be written in English. Spam, offensive content, impersonation, and private information will not be permitted. If any comment is reported and identified as inappropriate content by OAE staff, the comment will be removed without notice. If you have any queries or need any help, please contact us at support@oaepublish.com.